Maxigesic takes the lead

Maxigesic is outselling other paracetamol-ibuprofen brands in pharmacy There has been strong sales in schedule 3 30s packs, which the company says is significant as it means pharmacists are recommending it to patients. "For us to lead this category is encouraging because there are some heavily promoted brands we're competing against and our result has been

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Opioids not superior in chronic back pain
Next EpiPen supply returning to normal